ClinVar Miner

Submissions for variant NM_015335.5(MED13L):c.1991C>T (p.Ser664Leu)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center RCV004784979 SCV005397284 uncertain significance Cardiac anomalies - developmental delay - facial dysmorphism syndrome 2021-08-03 criteria provided, single submitter clinical testing This sequence variant is a single nucleotide substitution (C>T) which results in a serine to leucine amino acid change at residue 664 of the MED13L protein. This variant has not been previously reported in medical genetics databases or literature in individuals with MED13L-related disease, to our knowledge. This variant is rare in the gnomAD control population dataset (2/249920 alleles, 0.0008%). Ser664 occurs near a LXXLL receptor-binding motif at amino acid residues 669-673 (Uniprot). Multiple bioinformatic tools predict that this serine to leucine amino acid change is likely to be tolerated, and the Ser664 residue is moderately conserved in mammals. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider it to be a variant of uncertain significance. ACMG Criteria: BP4, PM2

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.